ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

DELORES MACKSOUD M.D.

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,143Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 1290

$2.36M Total Retail Price of All Prescriptions

Rank: 6 out of 1290

1,127 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 11,899 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

40% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$167 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
DONEPEZIL HCL 1,512 1,464 1 13
NAMENDA 1,078 1,056 2 27
GABAPENTIN 1,066 905 3 8
CARBIDOPA-LEVODOPA 710 667 4 43
EXELON 593 581 5 95
ROPINIROLE HCL 402 356 6 146
ESCITALOPRAM OXALATE 394 372 7 63
ARICEPT 308 299 10 8 281
ZOLPIDEM TARTRATE 300 237 9 15
PRAMIPEXOLE DIHYDROCHLORIDE 299 268 10 190
CYMBALTA 281 257 11 59
CLOPIDOGREL 276 267 12 24
LEVETIRACETAM 242 184 13 70
LYRICA 232 167 14 94
CARBAMAZEPINE 217 104 15 191
VOLTAREN 208 166 16 107
PLAVIX 205 190 17 32
RIVASTIGMINE 189 189 18 329
MECLIZINE HCL 178 162 19 159
AZILECT 177 164 20 231
PRIMIDONE 163 145 21 127
TRIHEXYPHENIDYL HCL 162 153 R 22 298
ALPRAZOLAM 158 130 23 47
LEXAPRO 150 132 24 173
TOPIRAMATE 145 60 25 91
SEROQUEL XR 145 144 25 151
TEMAZEPAM 133 104 27 71
PAROXETINE HCL 130 92 28 84
BACLOFEN 128 48 29 122
GALANTAMINE HBR 120 120 30 183
LIDODERM 119 88 31 113
AMITRIPTYLINE HCL 117 78 R 32 97
PHENYTOIN SODIUM EXTENDED 111 69 33 203
QUETIAPINE FUMARATE 105 103 34 80
AGGRENOX 100 100 35 308
CITALOPRAM HBR 95 88 36 29
COMTAN 89 89 37 494
DIVALPROEX SODIUM 88 25 38 121
CARBIDOPA-LEVODOPA-ENTACAPONE 85 82 39 416
STALEVO 150 84 84 10 40 483
TRAMADOL HCL 82 50 41 25
CLONAZEPAM 82 57 41 170
STALEVO 200 82 82 10 41 498
AMANTADINE 79 69 44 363
OXCARBAZEPINE 77 62 45 228
STALEVO 100 73 61 46 555
PHENOBARBITAL 72 52 R 10 47 559
LORAZEPAM 68 47 48 132
FOLIC ACID 67 61 49 188
IBUPROFEN 66 33 50 74
MIRAPEX ER 64 64 51 583
SERTRALINE HCL 63 48 52 36
DIVALPROEX SODIUM ER 59 19 53 197
SEROQUEL 57 54 54 186
PYRIDOSTIGMINE BROMIDE 56 53 55 482
LUNESTA 52 40 56 370
REQUIP XL 51 46 57 641
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.